Telix Pharmaceuticals (ASX:TLX) received notice that JPMorgan Chase and its affiliates increased their holdings in the company to 6.62% from 5.54%, according to a Monday filing with the Australian bourse.
JPMorgan Chase and its affiliates now own 22.4 million shares in the company, the filing said.
The company's shares fell around 1% in recent Monday trade.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.